Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

作者: H.C. Ringvold , R.A. Khalil

DOI: 10.1016/BS.APHA.2016.06.002

关键词: PhosphorylationMyosin light-chain kinaseCaldesmonVascular smooth muscleProtein kinase CPhosphataseKinaseCell biologyChelerythrineBiology

摘要: Abstract Vascular smooth muscle (VSM) plays an important role in maintaining vascular tone. In addition to Ca 2 + -dependent myosin light chain (MLC) phosphorylation, protein kinase C (PKC) is a major regulator of VSM function. PKC family conventional α, β, and γ, novel -independent δ, ɛ, θ, η, atypical ξ, ι/λ isoforms. Inactive mainly cytosolic, upon activation it undergoes maturation, translocation the surface membrane, nucleus, endoplasmic reticulum, other cell organelles; process facilitated by scaffold proteins such as RACKs. Activated phosphorylates different substrates including ion channels, pumps, nuclear proteins. also CPI-17 leading inhibition MLC phosphatase, increased enhanced contraction. could initiate cascade kinases phosphorylation actin-binding calponin caldesmon, actin–myosin interaction, Increased activity has been associated with disorders ischemia–reperfusion injury, coronary artery disease, hypertension, diabetic vasculopathy. inhibitors test systems reduce hyperactivity disorders. First-generation staurosporine chelerythrine are not very specific. Isoform-specific ruboxistaurin have tested clinical trials. Target delivery pseudosubstrate inhibitory peptides siRNA may be useful localized disease. Further studies its should help design isoform-specific modulators that experimentally potent clinically safe target

参考文章(448)
Flavio Meggio, Arianna Donella Deana, Maria Ruzzene, Anna M. Brunati, Luca Cesaro, Barbara Guerra, Thomas Meyer, Helmut Mett, Doriano Fabbro, Pascal Furet, Grazyna Dobrowolska, Lorenzo A. Pinna, Different susceptibility of protein kinases to staurosporine inhibition Kinetic studies and molecular bases for the resistance of protein kinase CK2 FEBS Journal. ,vol. 234, pp. 317- 322 ,(1995) , 10.1111/J.1432-1033.1995.317_C.X
Rouba Hage-Sleiman, Asmaa B. Hamze, Lina Reslan, Hadile Kobeissy, Ghassan Dbaibo, The Novel PKCθ from Benchtop to Clinic Clinical & Developmental Immunology. ,vol. 2015, pp. 348798- 348798 ,(2015) , 10.1155/2015/348798
Alex TOKER, Christine A. ELLIS, Lynda A. SELLERS, Alastair AITKEN, Protein kinase C inhibitor proteins. Purification from sheep brain and sequence similarity to lipocortins and 14-3-3 protein. FEBS Journal. ,vol. 191, pp. 421- 429 ,(1990) , 10.1111/J.1432-1033.1990.TB19138.X
Rayudu Gopalakrishna, Susan Jaken, Protein kinase C signaling and oxidative stress Free Radical Biology and Medicine. ,vol. 28, pp. 1349- 1361 ,(2000) , 10.1016/S0891-5849(00)00221-5
Kyoji TAGUCHI, Kotomi KANEKO, Takao KUBO, Protein kinase C modulates Ca2+-activated K+ channels in cultured rat mesenteric artery smooth muscle cells. Biological & Pharmaceutical Bulletin. ,vol. 23, pp. 1450- 1454 ,(2000) , 10.1248/BPB.23.1450
Mary O. Gray, Joel S. Karliner, Daria Mochly-Rosen, A Selective ε-Protein Kinase C Antagonist Inhibits Protection of Cardiac Myocytes from Hypoxia-induced Cell Death Journal of Biological Chemistry. ,vol. 272, pp. 30945- 30951 ,(1997) , 10.1074/JBC.272.49.30945
Dorit Ron, Jianhua Luo, Daria Mochly-Rosen, C2 Region-derived Peptides Inhibit Translocation and Function of β Protein Kinase C in Vivo Journal of Biological Chemistry. ,vol. 270, pp. 24180- 24187 ,(1995) , 10.1074/JBC.270.41.24180
Francisco Perez-Vizcaino, Angel Cogolludo, Laura Moreno, None, Reactive oxygen species signaling in pulmonary vascular smooth muscle. Respiratory Physiology & Neurobiology. ,vol. 174, pp. 212- 220 ,(2010) , 10.1016/J.RESP.2010.08.009